Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 7 EP applications Sheena Alice Linehan has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11722243

CHIMERIC OSPA GENES, PROTEINS, AND METHODS OF USE THEREOF

IPC classification:
A61K 39/02, C07K 14/20
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11720967

OSPA CHIMERAS AND USE THEREOF IN VACCINES

IPC classification:
A61K 39/02, C07K 14/20
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11741727

NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE

IPC classification:
A61K 47/48
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12198754

Cell culture processes

IPC classification:
C07K 14/00, C12P 21/00
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
The patent has been granted
EP12198392

Cell culture processes

IPC classification:
C07K 14/00, C12P 21/00
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
The patent has been granted
EP13150822

Lyophilized recombinant VWF formulations

IPC classification:
A61K 9/08, A61K 9/19, A61K 38/16, A61K 38/36, A61K 47/12, A61K 47/18, A61K 47/26, A61K 48/00
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11720255

BIFUNCTIONAL MOLECULES FOR INACTIVATING HIV AND BLOCKING HIV

IPC classification:
A61K 38/16, C07K 14/16
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature